Cardiff Oncology, Inc. (CRDF) Other Assets, Noncurrent USD 2011 - 2024

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
Cardiff Oncology, Inc. quarterly Other Assets, Noncurrent history and growth rate from 2011 to 2024.
  • Cardiff Oncology, Inc. Other Assets, Noncurrent for the quarter ending March 31, 2024 was $1.28 M, a 6.32% decline year-over-year.
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 $1.28 M -$86 K -6.32% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $1.28 M -$108 K -7.79% Dec 31, 2023 10-Q 2024-05-02
Q3 2023 $1.39 M +$1.2 M +654% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $1.39 M +$1.21 M +651% Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $1.36 M +$1.17 M +624% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $1.39 M +$1.15 M +480% Dec 31, 2022 10-K 2024-02-29
Q3 2022 $184 K +$41 K +28.7% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 $185 K -$78 K -29.7% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 $188 K -$50 K -21% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 $239 K -$165 K -40.8% Dec 31, 2021 10-K 2023-03-02
Q3 2021 $143 K -$12.8 K -8.2% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 $263 K +$110 K +72.4% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 $238 K +$81.6 K +52.2% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 $404 K +$246 K +156% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $156 K -$15.2 K -8.88% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 $153 K +$17.3 K +12.8% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $156 K +$69.3 K +79.6% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 $158 K +$54.8 K +53.3% Dec 31, 2019 10-K 2021-02-25
Q3 2019 $171 K -$78.7 K -31.5% Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $135 K -$185 K -57.8% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $87.1 K -$258 K -74.8% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 $103 K -$287 K -73.6% Dec 31, 2018 10-K 2020-02-27
Q3 2018 $250 K -$290 K -53.7% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 $321 K -$263 K -45.1% Jun 30, 2018 10-Q 2018-08-03
Q1 2018 $345 K -$283 K -45.1% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 $390 K -$783 K -66.8% Dec 31, 2017 10-K 2019-03-06
Q3 2017 $539 K +$168 K +45.3% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 $584 K +$213 K +57.3% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 $629 K +$257 K +69.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 $1.17 M +$799 K +214% Dec 31, 2016 10-K 2018-02-26
Q3 2016 $371 K +$8.3 K +2.29% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $371 K +$8.3 K +2.29% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 $371 K +$34.5 K +10.3% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $374 K +$37.3 K +11.1% Dec 31, 2015 10-K 2017-03-15
Q3 2015 $363 K +$16 K +4.63% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 $363 K +$16 K +4.63% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 $337 K +$258 +0.08% Mar 31, 2015 10-Q 2015-05-05
Q4 2014 $337 K +$258 +0.08% Dec 31, 2014 10-K 2016-03-10
Q3 2014 $347 K -$65 K -15.8% Sep 30, 2014 10-Q 2014-11-06
Q2 2014 $347 K -$184 K -34.6% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 $336 K -$182 K -35.1% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 $336 K -$25.6 K -7.08% Dec 31, 2013 10-K 2015-03-12
Q3 2013 $412 K +$49.8 K +13.8% Sep 30, 2013 10-Q 2013-11-14
Q2 2013 $531 K +$169 K +46.5% Jun 30, 2013 10-Q 2013-08-14
Q1 2013 $519 K +$157 K +43.3% Mar 31, 2013 10-Q 2013-05-14
Q4 2012 $362 K +$188 K +107% Dec 31, 2012 10-K 2014-03-17
Q3 2012 $362 K Sep 30, 2012 10-Q 2012-11-14
Q2 2012 $362 K Jun 30, 2012 10-Q 2012-08-14
Q1 2012 $362 K Mar 31, 2012 10-Q 2012-05-15
Q4 2011 $175 K Dec 31, 2011 10-K 2013-04-01
* An asterisk sign (*) next to the value indicates that the value is likely invalid.